Literature DB >> 9824639

TGF-beta and FGF-trigger intercellular induction of apoptosis: analogous activity on non-transformed but differential activity on transformed cells.

S Dormann1, G Bauer.   

Abstract

Transforming growth factor (TGF)-beta as well as fibroblast growth factor (FGF) are able to trigger intercellular induction of apoptosis. Interaction of either cytokine with non-transformed cells results in the production and release of apoptosis inducing factor (AIF) which is specifically directed against transformed cells. In both cases, AIF production is inhibited by the antioxidant N-Acetylcysteine, indicating that similar or identical signalling pathways are utilized. Whereas TGF-beta sensitizes transformed cells by down modulation of their endogenous survival factors, FGF is devoid of a similar activity. Therefore TGF-beta triggers and enhances intercellular induction of apoptosis by interaction with non-transformed and transformed cells, whereas the activity of FGF is based only on the interaction with non-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824639     DOI: 10.3892/ijo.13.6.1247

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Protective bystander effects simulated with the state-vector model.

Authors:  Helmut Schöllnberger; Peter M Eckl
Journal:  Dose Response       Date:  2007-06-26       Impact factor: 2.658

Review 2.  Palatal seam disintegration: to die or not to die? that is no longer the question.

Authors:  Ali Nawshad
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

3.  Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3.

Authors:  Shaheen Ahmed; Chang-Chih Liu; Ali Nawshad
Journal:  Dev Biol       Date:  2007-06-29       Impact factor: 3.582

4.  Low-dose radiation and genotoxic chemicals can protect against stochastic biological effects.

Authors:  Bobby R Scott; Dale M Walker; Vernon E Walker
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.